Literature DB >> 1412164

Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.

E J Brommer1, G Dooijewaard, B A Dijkmans, F C Breedveld.   

Abstract

Inflammatory processes are accompanied by extravascular deposition and breakdown of fibrin. We measured fibrinolytic parameters in synovial fluid (SF) and in plasma of 36 patients with rheumatoid arthritis (RA). As a control, SF of 13 patients with blunt knee trauma, and plasma of 17 healthy volunteers were studied. In RA patients, extravascular t-PA mediated plasminogen activation was depressed: mean SF tissue-type plasminogen activator (t-PA:Ag) concentration (2.1 +/- 1.6 ng/ml) was four-fold lower, and plasminogen activator inhibitor (PAI) activity (284 +/- 212%) four-fold higher than the plasma values of the same patients or of healthy donors. In contrast, u-PA related plasminogen activation was strongly enhanced: urokinase-type plasminogen activator (u-PA) antigen (23.1 +/- 12.4 ng/ml) was more than four-fold higher, single-chain u-PA (scu-PA) (5.3 +/- 1.9 ng/ml) three-fold higher than in plasma of the same patients or of healthy donors, and active two-chain u-PA (tcu-PA) was detected in 14 of the 36 SF samples of RA patients. All of these changes in extravascular fibrinolytic parameters correspond with those induced by inflammatory mediators in cell cultures. In joint effusions of patients with a blunt knee trauma, the effects were intermediate: u-PA related parameters showed moderate changes in the same direction as in arthritis; t-PA antigen was also decreased. The only exception was that PAI was not increased. We conclude that the findings in traumatic effusions reflect transient effects as a reaction to trauma. In joint inflammation, the depressed t-PA mediated plasminogen activation, although more than compensated by the enhanced u-PA mediated plasminogen activation, results in protraction of fibrin removal. Besides, the enhanced u-PA activation might lead to proteolytic damage of the cartilage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1412164

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

Review 1.  Urokinase in rheumatoid arthritis: causal or coincidental?

Authors:  N Busso; A So
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

2.  Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.

Authors:  N Busso; V Péclat; A So; A P Sappino
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

3.  Specific conformational changes of plasminogen induced by chloride ions, 6-aminohexanoic acid and benzamidine, but not the overall openness of plasminogen regulate, production of biologically active angiostatins.

Authors:  Debra J Warejcka; Sally S Twining
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

4.  Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues.

Authors:  Z Szekanecz; G K Haines; A E Koch
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

Review 5.  The potential for primary repair of the ACL.

Authors:  Patrick Vavken; Martha M Murray
Journal:  Sports Med Arthrosc Rev       Date:  2011-03       Impact factor: 1.985

Review 6.  Bench-to-bedside: Bridge-enhanced anterior cruciate ligament repair.

Authors:  Gabriel S Perrone; Benedikt L Proffen; Ata M Kiapour; Jakob T Sieker; Braden C Fleming; Martha M Murray
Journal:  J Orthop Res       Date:  2017-07-09       Impact factor: 3.494

7.  Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis.

Authors:  O Slot; N Brünner; H Locht; P Oxholm; R W Stephens
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

8.  Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease.

Authors:  Jakub Kwieciński; Elisabet Josefsson; Tao Jin
Journal:  Inflamm Res       Date:  2011-07-24       Impact factor: 4.575

9.  Exacerbation of antigen-induced arthritis in urokinase-deficient mice.

Authors:  N Busso; V Péclat; K Van Ness; E Kolodziesczyk; J Degen; T Bugge; A So
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  PAST, CURRENT AND FUTURE INTERVENTIONAL ORTHOBIOLOGICS TECHNIQUES AND HOW THEY RELATE TO REGENERATIVE REHABILITATION: A CLINICAL COMMENTARY.

Authors:  Christopher J Centeno; Sarah M Pastoriza
Journal:  Int J Sports Phys Ther       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.